Avidity Biosciences Competitors and Similar CompaniesClear all
Avidity Biosciences's competitors and similar companies include Argenx.
 Avidity Biosciences Avidity Biosciences is a biotech company developing oligonucleotide-based therapies called antibody oligonucleotide conjugates (AOC). |  Argenx Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. | |
Founding Date | Founding Date 2013 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Gent, BE HQ Minato City, JP Breda, NL Genève, CH Boston, US |
Employees | Employees 25336% increase | Employees 1,599 |
Valuation ($) | Valuation ($) 5.3 b | Valuation ($) 33.7 b |
Financial | ||
Revenue (est.) | Revenue (est.) $18.8m (FY, 2025) | Revenue (est.) $4.2b (FY, 2025) |
Net income | Net income ($684.6m) (FY, 2025) | Net income $1.3b (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 131m | Total funding raised $ 396.8m |
For sources of this data, please see the company profile
View Company Profiles
Argenx
HQ
Gent, BE
Employees
1,599
Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer.
View company